Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Heart Failure

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 57 articles:
HTML format



Single Articles


    November 2021
  1. PFEFFER MA, Claggett B, Lewis EF, Granger CB, et al
    Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
    N Engl J Med. 2021;385:1845-1855.
    PubMed     Abstract available


    September 2021
  2. KITZMAN DW, Pastva AM, Mentz RJ
    Physical Rehabilitation in Patients with Heart Failure. Reply.
    N Engl J Med. 2021;385:1340-1341.
    PubMed    


  3. DUPONT J, Koppo K, Gielen E
    Physical Rehabilitation in Patients with Heart Failure.
    N Engl J Med. 2021;385:1340.
    PubMed    


  4. SCHUTTLER D, Weckbach LT, Brunner S
    Physical Rehabilitation in Patients with Heart Failure.
    N Engl J Med. 2021;385:1339-1340.
    PubMed    


  5. FRUSH BW
    Cool Water.
    N Engl J Med. 2021;385:1254-1255.
    PubMed    


    August 2021
  6. ANKER SD, Butler J, Filippatos G, Ferreira JP, et al
    Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
    N Engl J Med. 2021 Aug 27. doi: 10.1056/NEJMoa2107038.
    PubMed     Abstract available


  7. DRAZNER MH
    SGLT2 Inhibition in Heart Failure with a Preserved Ejection Fraction - A Win against a Formidable Foe.
    N Engl J Med. 2021 Aug 27. doi: 10.1056/NEJMe2113008.
    PubMed    


  8. PACKER M, Butler J, Zannad F, Pocock SJ, et al
    Empagliflozin and Major Renal Outcomes in Heart Failure.
    N Engl J Med. 2021 Aug 27. doi: 10.1056/NEJMc2112411.
    PubMed    


  9. JOYNT MADDOX KE, Orav EJ, Zheng J, Epstein AM, et al
    Year 1 of the Bundled Payments for Care Improvement-Advanced Model.
    N Engl J Med. 2021;385:618-627.
    PubMed     Abstract available


    May 2021
  10. TEERLINK JR, Felker GM, McMurray JJV
    Omecamtiv Mecarbil in Systolic Heart Failure. Reply.
    N Engl J Med. 2021;384:1967-1968.
    PubMed    


  11. BELLUMKONDA L
    Omecamtiv Mecarbil in Systolic Heart Failure.
    N Engl J Med. 2021;384:1967.
    PubMed    


  12. BONAPACE S, Molon G
    Omecamtiv Mecarbil in Systolic Heart Failure.
    N Engl J Med. 2021;384:1967.
    PubMed    


  13. KOMAMURA K
    Omecamtiv Mecarbil in Systolic Heart Failure.
    N Engl J Med. 2021;384:1966-1967.
    PubMed    


  14. YEKU OO, Medford AJ, Fenves AZ, Uljon SN, et al
    Case 15-2021: A 76-Year-Old Woman with Nausea, Diarrhea, and Acute Kidney Failure.
    N Engl J Med. 2021;384:1943-1950.
    PubMed    


  15. ANKER SD, Coats AJS
    Exercise for Frail, Elderly Patients with Acute Heart Failure - A Strong Step Forward.
    N Engl J Med. 2021 May 16. doi: 10.1056/NEJMe2106140.
    PubMed    


  16. KITZMAN DW, Whellan DJ, Duncan P, Pastva AM, et al
    Physical Rehabilitation for Older Patients Hospitalized for Heart Failure.
    N Engl J Med. 2021 May 16. doi: 10.1056/NEJMoa2026141.
    PubMed     Abstract available


    April 2021
  17. LEE TH
    Zoom Family Meeting.
    N Engl J Med. 2021;384:1586-1587.
    PubMed    


    January 2021
  18. PACKER M, Zannad F
    Empagliflozin in Heart Failure. Reply.
    N Engl J Med. 2021;384:387-388.
    PubMed    


  19. KUMAR S, Sinha S
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:387.
    PubMed    


  20. GERARD AO, Favre G, Esnault VLM
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:386-387.
    PubMed    


  21. SHANMUGANATHAN M, Goswami RM
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:386.
    PubMed    


  22. BHATTACHARYYA D, Kar A
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:385-386.
    PubMed    


  23. FAUCHIER L, Fauchier G, Angoulvant D
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:385.
    PubMed    


  24. LIN X, Wang S, Huang J
    Empagliflozin in Heart Failure.
    N Engl J Med. 2021;384:384-385.
    PubMed    


  25. SWEDBERG K
    Stimulation of Contractility in Systolic Heart Failure.
    N Engl J Med. 2021;384:178-179.
    PubMed    


  26. RUDDER M, Russo M, Ventetuolo CE
    Breathing for Two.
    N Engl J Med. 2021;384:61-68.
    PubMed    


    November 2020
  27. BHATT DL, Szarek M, Steg PG, Cannon CP, et al
    Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
    N Engl J Med. 2020 Nov 16. doi: 10.1056/NEJMoa2030183.
    PubMed     Abstract available


  28. TEERLINK JR, Diaz R, Felker GM, McMurray JJV, et al
    Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
    N Engl J Med. 2020 Nov 13. doi: 10.1056/NEJMoa2025797.
    PubMed     Abstract available


    October 2020
  29. ARMSTRONG PW, Anstrom KJ, O'Connor CM
    Vericiguat in Heart Failure with Reduced Ejection Fraction. Reply.
    N Engl J Med. 2020;383:1497-1498.
    PubMed    


  30. RYAN JJ, Maron BA
    Vericiguat in Heart Failure with Reduced Ejection Fraction.
    N Engl J Med. 2020;383:1497.
    PubMed    


  31. WEARDEN J, Hough A, Kaiser S
    Vericiguat in Heart Failure with Reduced Ejection Fraction.
    N Engl J Med. 2020;383:1496-1497.
    PubMed    


    August 2020
  32. JARCHO JA
    More Evidence for SGLT2 Inhibitors in Heart Failure.
    N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMe2027915.
    PubMed    


  33. PACKER M, Anker SD, Butler J, Filippatos G, et al
    Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
    N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMoa2022190.
    PubMed     Abstract available


  34. KIRCHHOF P, Camm AJ, Goette A, Brandes A, et al
    Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
    N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMoa2019422.
    PubMed     Abstract available


    June 2020
  35. LEGRAND M, Rossignol P
    Cardiovascular Consequences of Acute Kidney Injury.
    N Engl J Med. 2020;382:2238-2247.
    PubMed    


    May 2020
  36. BURNETT JC JR
    Vericiguat - Another Victory for Targeting Cyclic GMP in Heart Failure.
    N Engl J Med. 2020;382:1952-1953.
    PubMed    


    April 2020
  37. EPSTEIN JA, Rosenthal N, Feldman AM
    Teasing the Immune System to Repair the Heart.
    N Engl J Med. 2020;382:1660-1662.
    PubMed    


    March 2020
  38. ARMSTRONG PW, Pieske B, Anstrom KJ, Ezekowitz J, et al
    Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.
    N Engl J Med. 2020 Mar 28. doi: 10.1056/NEJMoa1915928.
    PubMed     Abstract available


  39. SOLOMON SD, McMurray JJV
    Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. Reply.
    N Engl J Med. 2020;382:1182-1183.
    PubMed    


  40. LEWIS GA, Schelbert EB, Miller CA
    Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2020;382:1182.
    PubMed    


  41. YAZDANI B, Lutz N, Kramer BK
    Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2020;382:1181-1182.
    PubMed    


  42. BAPTISTA R, Moraes-Sarmento P, Fontes-Carvalho R
    Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2020;382:1181.
    PubMed    


  43. GUPTA K, Bajaj NS
    Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2020;382:1180-1181.
    PubMed    


  44. VAN DE BOVENKAMP AA, van Rossum AC, Handoko ML
    Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
    N Engl J Med. 2020;382:1180.
    PubMed    


  45. MCMURRAY JJV, Docherty KF, Jhund PS
    Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. Reply.
    N Engl J Med. 2020;382:973.
    PubMed    


  46. VIEIRA JL, Mehra MR
    Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
    N Engl J Med. 2020;382:972-973.
    PubMed    


  47. PELED H, Dau NQ
    Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
    N Engl J Med. 2020;382:972.
    PubMed    


  48. BORGHI C, Cicero AFG
    Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
    N Engl J Med. 2020;382:972.
    PubMed    


    February 2020
  49. PAULUS WJ
    Unfolding Discoveries in Heart Failure.
    N Engl J Med. 2020;382:679-682.
    PubMed    


  50. D'SILVA K, Cockrill B, Anderson WJ, Miller AL, et al
    A Rapid Change in Pressure.
    N Engl J Med. 2020;382:563-570.
    PubMed    


    January 2020
  51. AZAR MM, Muse VV, Villalba JA, Turbett SE, et al
    Case 2-2020: A 64-Year-Old Man with Fever and Respiratory Failure.
    N Engl J Med. 2020;382:276-285.
    PubMed    


    December 2019
  52. PACKER M
    Why Are Physicians So Confused about Acute Heart Failure?. Reply.
    N Engl J Med. 2019;381:2375-2376.
    PubMed    


  53. FINUCANE TE
    Why Are Physicians So Confused about Acute Heart Failure?
    N Engl J Med. 2019;381:2375.
    PubMed    


  54. ELLISON DH
    Why Are Physicians So Confused about Acute Heart Failure?
    N Engl J Med. 2019;381:2374-2375.
    PubMed    


    November 2019
  55. KITTLESON MM
    A Good Physician - On Complacency and Communication.
    N Engl J Med. 2019;381:1798-1799.
    PubMed    


    October 2019
  56. O'CONNOR CM, deFilippi C
    PARAGON-HF - Why We Do Randomized, Controlled Clinical Trials.
    N Engl J Med. 2019;381:1675-1676.
    PubMed    


  57. BERNSTEIN SN, Cudemus-Deseda GA, Ortiz VE, Goodman A, et al
    Case 33-2019: A 35-Year-Old Woman with Cardiopulmonary Arrest during Cesarean Section.
    N Engl J Med. 2019;381:1664-1673.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: